A recent clinical trial highlights how a high-fiber plant-based diet can improve health markers and potentially delay the ...

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk for developing ...

The Cancer Research UK analysis is the first to examine 50 years of national cancer data, revealing striking progress-but ...

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk of developing ...

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

Helena Yu, MD, discusses the importance of zipalertinib's oral administration route for patients with EGFRm non–small cell lung cancer.

Researchers at ASCO reviewing data from the ATOMIC trial said they will change practice based on the results but questioned ...

Turmeric is a popular dietary supplement for managing arthritis, digestive problems, and liver disease. However, some ...

Helena Yu, MD, discusses the efficacy of zipalertinib for EGFR-mutant non–small cell lung cancer and the importance of exploring therapies with CNS penetration in this space.

Conquer Cancer®, the ASCO Foundation, presented the 2025 Young Investigator Awards (YIAs) funded by Vaniam Grouptm and Women Leaders in Oncology® (WLO). These prestigious awards celebrate and support ...